Angélique Vienot

9PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Oct 06, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).

Marine Valery, Julien Edeline, Julie Henriques

|Aug 16, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancers.

Laurie Spehner, Adeline Bouard, Antoine El Kaddissi

|Jan 14, 2025
Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials.

Angélique Vienot, Dewi Vernerey, Adeline Bouard

|Jan 08, 2025
Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Caroline Truntzer, Dina Ouahbi, Titouan Huppé

|Sep 16, 2024
Targeting mTOR signaling for the treatment of intrahepatic cholangiocarcinoma with TSC1/ARID1A mutations: a case report with an unexpected response.

Clémentine Daugan, Romain Boidot, François Ghiringhelli

Pageof 2

Frequent Collaborators

2 joint publications

Stefano Kim

2 joint publications

Franck Monnien

2 joint publications

Adeline Bouard

2 joint publications

Christophe Borg